×

Do you want to link to other websites and leave Amgen.cn?

You are now leaving Amgen China website. Amgen China takes no responsibility for the information contained on the Amgen international server or site which you will be accessing. The information you are about to access may not comply with the China regulatory environment.

×

Do you want to link to other websites and leave Amgen.cn?

You are now leaving Amgen China website. Amgen China takes no responsibility for the information contained on the Amgen international server or site which you will be accessing. The information you are about to access may not comply with the China regulatory environment.

AMGEN FOUNDATION LAUNCHES AMGEN BIOTECH EXPERIENCE IN CHINA

News Releases
20 Sept 2017
Amgen Foundation Launches Amgen Biotech Experience In China

Long-Established Science Education Program to Give 3,000 Local Secondary School Students Hands-On Biotechnology Lab Experience

SHANGHAI (Sept. 20, 2017) – The Amgen Foundation, in partnership with Shanghai Jiao Tong University, today announced the launch of the Amgen Biotech Experience (ABE) program in China, as part of a $10.5 million investment in the longstanding science education program. Globally, ABE is expected to reach nearly 900,000 secondary school students by 2020 in 18 regions around the world.

For nearly 30 years, ABE has empowered high school science teachers to implement real-world biotechnology labs in their classrooms, helping their students better understand science and how it influences their daily lives. The three-week in-class lab initiative provides teachers professional development, teaching materials, and research-grade equipment to classrooms to immerse students in the concepts and techniques scientists use to discover and develop medicines.

The Amgen Foundation's total past and current commitment to ABE now reaches more than $25 million, bringing the Foundation's total commitment to science, technology, engineering and math (STEM) education to more than $125 million globally.

“Science-driven is the core of Amgen value,” said Wenjie Zhang, general manager at Amgen China. “We are not only committed to providing Chinese patients with advanced therapeutic solutions, but also seeking to advance excellence in science education to young generation. We are excited to see how ABE will inspire Chinese students in science and help foster future scientists.”

Results of an independent and rigorous evaluation by WestEd found that ABE students have shown significant and substantial gains in biotechnology learning as well as increased confidence and interest in doing science and biotechnology. Preliminary results show that:

  • students had a statistically significant increase of their biotechnology knowledge and skills (p < 0.001);
  • students averaged a 20 percent increase between pre- and post-test scores;
  • 82 percent of students got new ideas about what happens in science labs;
  • 72 percent of students got new ideas about what science is;
  • 53 percent of students are more interested in learning about scientific research;
  • 53 percent of students report increased interest in science careers from ABE participation.

Separately, Change the Equation, a coalition working to improve STEM literacy, distinguished ABE with the highest possible ranking in STEMworks, its database of effective STEM education programs. Business leaders, funders and STEM advocates use STEMworks to find proven, scalable programs to help them maximize their impact on STEM education.

In China, ABE is expected to engage nearly 15 teachers during the coming academic year. Recently, the Amgen Foundation announced ABE’s expansion to Australia, Canada, China, France, Germany, Hong Kong SAR, Italy, Netherlands and Singapore. The program is already underway in the United States, Puerto Rico, United Kingdom and Ireland.

Learn more about ABE by visiting AmgenBiotechExperience.com. To learn more about the Amgen Foundation’s other science education programs, visit AmgenInspires.com.

About the Amgen Foundation
The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work. To date, the Foundation has donated over $250 million to local, regional, and international nonprofit organizations that impact society in inspiring and innovative ways. The Amgen Foundation brings the excitement of discovery to the scientists of tomorrow through several signature programs, including Amgen Scholars, Amgen Biotech Experience, and Amgen Teach. For more information, visit www.amgeninspires.com and follow us on Twitter @AmgenFoundation.

About Amgen China

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Amgen established an affiliate in China in 2012, and has since opened its China Headquarters and Asia Research & Development Center in Shanghai. Amgen also has an office in Beijing, which is responsible for drug registration and clinical trials, with the aim to deliver its medicines to patients in China. For more information, visit www.amgen.cn.

About Shanghai Jiao Tong University

Shanghai Jiao Tong University (SJTU), as one of the higher education institutions which enjoy a long history and a world-renowned reputation in China, is a key university directly under the administration of the Ministry of Education (MOE) of the People's Republic of China and co-constructed by MOE and Shanghai Municipal Government. Through 121 years' unremitting efforts, SJTU has become a comprehensive, research-oriented, and internationalized top university in China.

SJTU has had 28 schools/departments, 21 research institutions, 13 affiliated hospitals, 2 affiliated medical research institute, 12 directly affiliated units and 6 directly affiliated enterprises. Today SJTU has 64 undergraduate programs covering 9 major disciplines: economics, law, literature, science, engineering, agriculture, medicine, management and arts. Up to now SJTU has 38 first-level disciplines authorized to offer doctorate degree covering 8 fields: economics, law, literature, science, engineering, agriculture, medicine and management; 56 first-level disciplines authorized to offer master degree covering all the 12 discipline fields; 3 disciplines authorized to offer professional doctorate degree; 23 disciplines authorized to offer professional master degree; 35 postdoctoral research station. For more information, visit www.sjtu.edu.cn.